How Tilray-MedMen deal could impact either cannabis company’s US aspirations
Last week, British Columbia-based Tilray (TLRY on Nasdaq, TSX), the second-largest Canadian licensed producer by market cap, announced a transaction to gain a substantial interest in U.S. cannabis retailer MedMen.
West Coast cannabis growers operating under ongoing threat of wildfire, smoke
Many cannabis growers on the West Coast have accepted the reality that wildfires and smoke are an unavoidable part of the late summer-fall growing season each year, while a few are considering other options.
The disconnect between US cannabis fundamentals and stock performance
There is a disconnect between fundamental performance and stock performance for U.S. cannabis companies, resulting in compressing valuations for those operations.
Booming Massachusetts marijuana market offers select cultivation, retail opportunities
After a slow start in late 2018, recreational marijuana sales in Massachusetts are surging – and on pace to exceed $1.2 billion this year and reach as much as $2.6 billion by 2025.
Cannabis growers seek solutions to water issues, including studying usage, monitoring theft
Cannabis growers in the American West haven’t escaped the massive water shortages this year that have forced farmers growing crops such as almonds and blueberries to rip out plants or let them die in the field.
Another Hydrofarm acquisition + Cuomo resignation’s impact on cannabis
On Aug. 3, Hydrofarm Holdings Group (Nasdaq: HYFM) closed its acquisition of Greenstar Plant Products, the latest in its series of acquisitions of plant-nutrient manufacturers and the largest closed cannabis M&A deal of the week.